JNJ
185.96
-1%↓
ABT
125.21
-1.57%↓
MDT
92.25
-1.86%↓
VEEV
288.4
-2.06%↓
A
145.51
-0.68%↓
JNJ
185.96
-1%↓
ABT
125.21
-1.57%↓
MDT
92.25
-1.86%↓
VEEV
288.4
-2.06%↓
A
145.51
-0.68%↓
JNJ
185.96
-1%↓
ABT
125.21
-1.57%↓
MDT
92.25
-1.86%↓
VEEV
288.4
-2.06%↓
A
145.51
-0.68%↓
JNJ
185.96
-1%↓
ABT
125.21
-1.57%↓
MDT
92.25
-1.86%↓
VEEV
288.4
-2.06%↓
A
145.51
-0.68%↓
JNJ
185.96
-1%↓
ABT
125.21
-1.57%↓
MDT
92.25
-1.86%↓
VEEV
288.4
-2.06%↓
A
145.51
-0.68%↓
24u
Huidig
Min
2.5
Max
2.55
Aanbevelingen | Buy |
|---|---|
12 Maanden Prognose | +464.2% upside |
Volgende Winsten | 12 nov 2025 |
|---|
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
1 okt 2025, 15:07 UTC
Fortress Biotech Shares Drop After FDA Letter for CUTX-101 Manufacturing Facility
DJ
Lezen
10 mrt 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Lezen
10 mrt 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Lezen
10 mrt 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Lezen
10 mrt 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Lezen
10 mrt 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Lezen
10 mrt 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Lezen
10 mrt 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Lezen
Prijswijziging
By TipRanks
12 Maanden Prognose
Gemiddelde 14.5 USD 464.2%
Hoogste 17 USD
Laagste 12 USD
Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Fortress Biotech Inc - Dist. in de afgelopen 3 maanden.
By TipRanks
Buy
2 ratings
2
Buy
0
Hold
0
Sell
Gebaseerd op 2 analisten die aandelenratings hebben gegeven aan Fortress Biotech Inc - Dist in de afgelopen 3 maanden.
$